Medical Director, Principal Investigator
Gregg Lucksinger, MD became interested in clinical research during a 1989 medical school rotation on the NIH schizophrenia research unit in Bethesda, Maryland. Ten years later, he co-founded a clinical research site next to his Family Medicine clinic, conducting high-volume Phase 2-3 clinical trials. Since then, Dr. Lucksinger has served as Principal Investigator on over 200 Phase 1-3 clinical trials in a variety of primary care indications in both inpatient and outpatient settings. He has a special interest in vaccine trials. Dr. Lucksinger joined the team at Velocity Clinical Research in 2020 and currently is the Medical Director of the Cedar Park, Texas location.
